MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2020-21)
- Udyam number
- UDYAM-DL-05-0002262
Genmission Pharmaceuticals Private Limited
Genmission Pharmaceuticals Private Limited - equipment & machinery in New Delhi, Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹79.86 Lakh
▲ 52% YoY
Net profit · FY 2025
₹1.85 Lakh
Net margin 2.3%
EBITDA · FY 2025
₹2.5 Lakh
EBITDA margin 3.1%
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
10 yrs
Est. 2016
Directors on board
2
As per MCA filings
Last financials
Mar 2025
Balance sheet date
About Genmission Pharmaceuticals Private Limited
Data last updated:
Genmission Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the other machinery segment of the industrial equipment and machinery sector. It was incorporated on 04 July 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U51599DL2016PTC302470.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Vrinda Chaturvedi and Santosh Kumar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at A – 212 Part – 3 Sonia Vihar, New Delhi, Delhi, India – 110094.
As per the financials filed for FY 2025, the company reported a revenue of ₹79.86 Lakh, a growth of 52% compared to the previous year. For the same year it recorded a net profit of ₹1.85 Lakh (net margin 2.3%) and EBITDA of ₹2.5 Lakh (EBITDA margin 3.1%).
Genmission Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-05-0002262). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U51599DL2016PTC302470
Registration Number 302470
Incorporation Date 04 July 2016
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-DL-05-0002262
Key People
Vrinda Chaturvedi Director Santosh Kumar Director Recognitions & Rankings of Genmission Pharmaceuticals
Contact details
Genmission Pharmaceuticals Private Limited's registered office is in New Delhi, Delhi. Its e-mail address is in the company report.
- Email
- Registered AddressA – 212 Part – 3 Sonia Vihar, New Delhi, Delhi, India – 110094
- IndustryEquipment & Machinery, Other Machinery, Equipment And Supplies, Machinery, Wholesale
To see the full contact details of Genmission Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Genmission Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Genmission Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Genmission Pharmaceuticals Private Limited, buy the company report.
Financials of Genmission Pharmaceuticals Private Limited
FY 2025 filings availableGenmission Pharmaceuticals Private Limited reported revenue of ₹79.86 Lakh (up 52% YoY) for FY 2025.
Revenue · FY 2025
₹79.86 Lakh ▲ 52%
Net profit · FY 2025
₹1.85 Lakh margin 2.3%
EBITDA · FY 2025
₹2.5 Lakh margin 3.1%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 52%
EBITDA CAGR growth
1 year
▲ 76%
3 years · compounded
▲ 116%
5 years · compounded
▲ 99%
Revenue rose 52% in the latest year. EBITDA rose 76% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.5 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.85 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.1% | ||||
| Net Profit Margin | 2.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Genmission Pharmaceuticals Private Limited, buy the company report.
Board of directors of Genmission Pharmaceuticals Private Limited
Genmission Pharmaceuticals has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vrinda Chaturvedi Also directs: Bulwark Techsoft LLP | Director | 18 Mar 2023 | 3 Years 7 Months | Current |
| Santosh Kumar | Director | 17 Dec 2016 | 9 Years 10 Months | Current |
Peer comparison
Genmission Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Loyol Pharmaceuticals Private Limited | ₹80.32 Lakh (FY 2021) | Balasore, Odisha, India | ||||
| Panicle Pharmaceuticals Private Limited | ₹80.26 Lakh (FY 2025) | 9.0% | Delhi, India | |||
| Genmission Pharmaceuticals Private Limitedthis company | ₹79.86 Lakh (FY 2025) | ₹1.85 Lakh | 2.3% | 52.0% | New Delhi, Delhi, India | |
| Agshov Pharmaceuticals Private Limited | ₹78.43 Lakh (FY 2024) | 9.0% | North Twenty Four Pargana, West Bengal, India |
To see the full peer comparison of Genmission Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Genmission Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Genmission Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Genmission Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Genmission Pharmaceuticals Private Limited has 6 board changes on record since 2016: 2 appointments and 4 cessations. The latest: Vrinda Chaturvedi was appointed as Director on 18 Mar 2023.
AGM
Genmission Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Genmission Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi.
Appointed
Vrinda Chaturvedi was appointed as Director.
Ceased
Kesh Ram ceased to be Additional Director.
Ceased
Santosh Kumar ceased to be Additional Director.
Ceased
Ajay Kumar Agarwal ceased to be Director.
Ceased
Sammay Deen ceased to be Director.
Appointed
Santosh Kumar was appointed as Director.
Incorporation
04 Jul 2016
Genmission Pharmaceuticals Private Limited was registered on 04 Jul 2016 with Roc Delhi & aged 10 years 4 months as per MCA records.
Frequently asked questions
Genmission Pharmaceuticals is an active private limited company based in New Delhi, Delhi, India. The company works in other machinery, within the equipment and machinery industry. It was incorporated on 04 July 2016 (10+ years old) and is registered under CIN U51599DL2016PTC302470.
Genmission Pharmaceuticals has 2 current directors:
- Vrinda Chaturvedi - Director
- Santosh Kumar - Director
The latest financial statements of Genmission Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2017 are in the company report.
The CIN (Corporate Identification Number) of Genmission Pharmaceuticals is U51599DL2016PTC302470. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Genmission Pharmaceuticals was incorporated on 04 July 2016, making it 10+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Genmission Pharmaceuticals by revenue are Loyol Pharmaceuticals Private Limited, Panicle Pharmaceuticals Private Limited, Agshov Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Vrinda Chaturvedi was appointed as Director on 18 Mar 2023. Kesh Ram ceased to be Additional Director on 29 Dec 2017. Santosh Kumar ceased to be Additional Director on 29 Dec 2017. Genmission Pharmaceuticals has 6 board changes on record in total.
Yes, Genmission Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-05-0002262).
The registered office of Genmission Pharmaceuticals is at A – 212 Part – 3 Sonia Vihar, New Delhi, Delhi, India – 110094.
Genmission Pharmaceuticals operates in the equipment and machinery industry, in the other machinery segment.
The compliance status of Genmission Pharmaceuticals is compliant as of 25 August 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages